RMR Wealth Builders bought a new stake in Corteva (NYSE:CTVA) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor bought 2,112 shares of the company’s stock, valued at approximately $57,000.

A number of other large investors have also modified their holdings of the stock. Center for Financial Planning Inc. raised its stake in shares of Corteva by 63.5% during the 1st quarter. Center for Financial Planning Inc. now owns 1,102 shares of the company’s stock valued at $26,000 after buying an additional 428 shares during the last quarter. Campbell Wealth Management acquired a new stake in Corteva during the second quarter worth about $30,000. Beese Fulmer Investment Management Inc. purchased a new position in Corteva during the second quarter valued at approximately $35,000. AJO LP purchased a new position in Corteva during the second quarter valued at approximately $44,000. Finally, Meeder Asset Management Inc. lifted its holdings in Corteva by 35.6% in the first quarter. Meeder Asset Management Inc. now owns 2,221 shares of the company’s stock valued at $52,000 after acquiring an additional 583 shares during the period. Institutional investors own 78.27% of the company’s stock.

In other news, SVP Cornel B. Fuerer bought 2,000 shares of the stock in a transaction that occurred on Monday, August 10th. The stock was purchased at an average price of $25.01 per share, for a total transaction of $50,020.00. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Gregory R. Page bought 5,000 shares of the company’s stock in a transaction that occurred on Monday, August 10th. The stock was acquired at an average cost of $25.30 per share, for a total transaction of $126,500.00. Following the acquisition, the director now directly owns 35,758 shares of the company’s stock, valued at $904,677.40. The disclosure for this purchase can be found here. Insiders have purchased 9,010 shares of company stock worth $227,172 over the last 90 days. Insiders own 0.22% of the company’s stock.

A number of equities research analysts recently issued reports on the stock. KeyCorp raised shares of Corteva from a “sector weight” rating to an “overweight” rating and set a $31.00 price target on the stock in a research note on Tuesday, August 11th. Credit Suisse Group dropped their price target on Corteva from $31.00 to $28.00 and set a “neutral” rating for the company in a research report on Friday, August 7th. Monness Crespi & Hardt lowered shares of Corteva from a “neutral” rating to a “sell” rating and set a $24.00 price objective for the company. in a report on Monday, June 8th. Morgan Stanley lifted their price target on shares of Corteva from $27.00 to $29.00 and gave the company an “equal weight” rating in a research report on Tuesday, June 2nd. Finally, Vertical Research raised shares of Corteva from a “hold” rating to a “buy” rating and set a $31.00 price target on the stock in a research report on Tuesday, June 16th. One equities research analyst has rated the stock with a sell rating, eleven have assigned a hold rating and twelve have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $30.53.

Shares of NYSE:CTVA traded up $0.26 during trading on Wednesday, hitting $29.71. The company’s stock had a trading volume of 43,672 shares, compared to its average volume of 3,622,582. Corteva has a fifty-two week low of $20.38 and a fifty-two week high of $32.08. The business has a 50 day moving average price of $28.32 and a two-hundred day moving average price of $26.57. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.44 and a current ratio of 1.92. The company has a market capitalization of $22.05 billion, a PE ratio of 43.31, a P/E/G ratio of 2.35 and a beta of 0.87.

Corteva (NYSE:CTVA) last released its earnings results on Wednesday, August 5th. The company reported $1.26 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.20 by $0.06. Corteva had a return on equity of 4.67% and a net margin of 3.68%. The firm had revenue of $5.19 billion during the quarter, compared to analyst estimates of $5.36 billion. As a group, equities analysts expect that Corteva will post 1.35 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 15th. Stockholders of record on Friday, August 14th were given a dividend of $0.13 per share. This represents a $0.52 dividend on an annualized basis and a dividend yield of 1.75%. The ex-dividend date was Thursday, August 13th. Corteva’s dividend payout ratio is presently 36.36%.

About Corteva

Corteva, Inc provides agriculture products worldwide. The company develops and supplies germplasm and traits in corn, soybean, and sunflower seed markets. It also supplies products to the agricultural input industry that protect against weeds, insects and other pests, and diseases, as well as to enhance crop health.

Featured Article: What moving averages are used to define a golden cross?

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.